The current financial score of Encompass Health Corp is 8.21. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 1.60B, representing a year-over-year increase of 9.58%, while its net profit experienced a year-over-year increase of 8.33%.
The current valuation score of Encompass Health Corp is 8.57. Its current P/E ratio is 20.18, which is 54.46% below the recent high of 31.17 and 20.11% above the recent low of 16.12.
The current earnings forecast score of Encompass Health Corp is 8.86. The average price target is 146.49, with a high of 155.00 and a low of 126.32.
The current price momentum score of Encompass Health Corp is 2.01. Currently, the stock price is trading between the resistance level at 124.93 and the support level at 119.45, making it suitable for range-bound swing trading.
The current institutional shareholding score of Encompass Health Corp is 10.00. The latest institutional shareholding proportion is 102.77%, representing a quarter-over-quarter increase of 3.99%. The largest institutional shareholder is Joel Greenblatt, holding a total of 260.90K shares, representing 0.06% of shares outstanding, with 31.58% increase in holdings.
The current risk assessment score of Encompass Health Corp is 8.39. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.